LobbyingNational Certification Commission for Acupuncture and Oriental Medicine lobbying by quarter
National Certification Commission for Acupuncture and Oriental Medicine's latest lobbying report covers Q2 2025, at $6,666. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
National Certification Commission for Acupuncture and Oriental Medicine
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $10K | 1 |
| Q1 2023 | $10K | 1 |
| Q2 2023 | $10K | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $10K | 1 |
| Q1 2024 | $10K | 1 |
| Q2 2024 | $10K | 1 |
| Q3 2024 | $10K | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $10K | 1 |
| Q2 2025 | $6,666 | 1 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$53.3K · 11 reports
- Medicare and Medicaid$53.3K · 11 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES11 reports
- SENATE7 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
- Natl Institutes of Health (NIH)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Smithbucklin | $106.7K | 11 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/07/21for Q2 2025 | Smithbucklin | $6,666 |
| 25/04/18for Q1 2025 | Smithbucklin | $10K |
| 25/01/17for Q4 2024 | Smithbucklin | $10K |
| 24/10/18for Q3 2024 | Smithbucklin | $10K |
| 24/07/19for Q2 2024 | Smithbucklin | $10K |
| 24/04/22for Q1 2024 | Smithbucklin | $10K |
| 24/01/19for Q4 2023 | Smithbucklin | $10K |
| 23/10/20for Q3 2023 | Smithbucklin | $10K |
| 23/07/19for Q2 2023 | Smithbucklin | $10K |
| 23/04/20for Q1 2023 | Smithbucklin | $10K |
| 23/01/20for Q4 2022 | Smithbucklin | $10K |